← Open Payments lookup

DEBORAH EVANS: Open Payments

NPI 1891103073 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,172 in 56 payments from 13 companies in 2025. Trend: 2023 $912 · 2024 $1,167 · 2025 $1,172

Food & beverage: $1,172
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.5$176
Actelion Pharmaceuticals US, Inc.13$176
Novo Nordisk Inc4$160
Novartis Pharmaceuticals Corporation11$148
Bayer Healthcare Pharmaceuticals Inc.4$139
Alnylam Pharmaceuticals Inc.5$84
BridgeBio Pharma, Inc.3$58
AstraZeneca Pharmaceuticals LP3$57
United Therapeutics Corporation3$48
Kestra Medical Technology Services, Inc.1$41

Products named: JARDIANCE, LEQVIO, Ozempic, Kerendia, UPTRAVI, AMVUTTRA, OPSUMIT, Attruby.

Industry payments across AR — which companies pay providers there.